The Cancer Letter receives 8 journalism, design awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Cancer Letter received eight 2021 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists—five for journalism, and three for illustration.

During a year of reckoning on health equity, gender equality, and systemic racism, as the future of American democracy hung in the balance, The Cancer Letter’s work—recognized by SPJDC—focused on the resonance of Black Lives Matter in oncology, pervasive gender bias at America’s cancer centers, and tracking the impact of COVID-19.

The Cancer Letter’s entries recognized by SPJ include narrative journalism, interviews, surveys, infographics, illustrations and editorial cartoons. This is the second consecutive year The Cancer Letter has won an award for infographics. In a feature about sexual harassment reporting structures, the infographics are central to telling the story, and are recognized as part of the journalism award.

For the fourth consecutive year, The Cancer Letter has won first-place awards for illustration, and the second year The Cancer Letter has won awards for cartooning. The cartoons recognized this year accompany aguest editorial on medical charlatans who attached themselves to Stalin—and Trump. 

The cartoon connects President Donald Trump’s infamous comment on the healing power of household detergents with Joseph Stalin’s championing of the healing power of baking soda.

First-place awards:

Finalist awards:

TCL46-37
TCL46-17
Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

At a lecture at Yale Cancer Center recently, Robert A. Winn brandished a copy of a 32-year old booklet titled “Cancer at a Crossroads: A Report to Congress for the Nation,” using it as a show-and-tell prop in arguing that America’s cancer program is once again at a crossroads and therefore in urgent need of strategic thinking (The Cancer Letter, April 10, 2026).
Christian Hinrichs, co-director of the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence and chief of the Section of Cancer Immunotherapy, RWJBarnabas Health, has been awarded a four-year, $800,000 translational research grant from the V Foundation for Cancer Research to develop next-generation immunotherapies for cancers caused by human papillomavirus. 
Paul Goldberg
Editor & Publisher

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login